📢 𝐉𝐔𝐒𝐓 𝐈𝐍: 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment - $MSOS $Tilray Brands(TLRY.US) $Organigram(OGI.US) $SNDL(SNDL.US) $Canopy Growth(CGC.US)
SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally. It operates through fou...
The Pivot Pandemic: How Edge Players Are Hustling to Survive
Weekly Recap | SNDL +8.73%, consensus target sits above spot
Niche and Infrastructure Players Navigating 2026 Hurdles: From Data Center Power to Financial Licensing
SNDL completes EU-GMP audit at Atholville cannabis facility
SNDL releases transcript of Q2 2026 results conference call
SNDL: Revenue and margins declined, but cash flow improved and U.S. expansion is underway
📢 𝐉𝐔𝐒𝐓 𝐈𝐍: 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment - $MSOS $Tilray Brands(TLRY.US) $Organigram(OGI.US) $SNDL(SNDL.US) $Canopy Growth(CGC.US)
• $AMD(AMD.US)'s strong earnings forecast boosts its equity value by $100 billion, driven by AI growth.
• Samsung Electronics surpasses $1 trillion in market value, benefiting from AI investments. • $Alphabet(GOOGL.US) parent Alphabet is set to become the world's most valuable company, nearing a $5 trillion market cap. • AI spending is reshaping the tech market, with data becoming a crucial production factor. • $AMD(AMD.US) expects significant revenue growth in its data center business, projecting $11.2 billion for Q2. • The U.S. government plans to review AI models before release to ensure safety and security. • The SEC proposes allowing companies to report financials semiannually instead of quarterly. • $SNDL(SNDL.US) market value exceeds $200 billion, driven by demand for AI-related memory chips.📢 𝐉𝐔𝐒𝐓 𝐈𝐍: U.S. Reclassifies Medical Marijuana to Schedule III - AP
$Tilray Brands(TLRY.US) $SNDL(SNDL.US) $Organigram(OGI.US) $MSOS $TRUL $Aurora Cannabis(ACB.US) $Cronos(CRON.US) $Canopy Growth(CGC.US) 👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:➤ Trump administration moves medical marijuana to 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐈𝐈𝐈.➤ Shift reclassifies cannabis from 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐈 status.➤ Change applies to 𝐬𝐭𝐚𝐭𝐞-𝐥𝐢𝐜𝐞𝐧𝐬𝐞𝐝 medical marijuana operators.➤ Does not fully 𝐥𝐞𝐠𝐚𝐥𝐢𝐳𝐞 cannabis at federal level.➤ Opens door to expanded 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 and medical use.➤ Provides potential 𝐭𝐚𝐱 𝐫𝐞𝐥𝐢𝐞𝐟 for cannabis businesses.➤ Marks major shift in U.S. 𝐝𝐫𝐮𝐠 𝐩𝐨𝐥𝐢𝐜𝐲 and regulation.Source: Hardik Shah